DUBLIN, Sept. 24, 2020 /CNW/ — Endo International plc (NASDAQ:ENDP) today announced that it will present data relevant to the use of Qwo™ (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women during Vegas Cosmetic Surgery & Aesthetic Dermatology (VCS).
